Kaplan El
Impact in
-
- Streptococcal Infections and Treatments
-
- Antimicrobial Resistance in Staphylococcus
- Otolaryngology and Infectious Diseases
Papers in
-
- Streptococcal Infections and Treatments 11
- Neonatal and Maternal Infections 2
-
- Infective Endocarditis Diagnosis and Management 7
- Neuroendocrine Tumor Research Advances 1
- Co-authors
- Gerber Ma (2 shared papers)Schwartz Rh (1 shared paper)Leon Gordis (1 shared paper)Samuel Refetoff (1 shared paper)A L Bisno (1 shared paper)Richard R. Facklam (1 shared paper)John Kim (1 shared paper)C Watanakunakorn (1 shared paper)
- Journals
- Circulation (1 paper)European Journal of Endocrinology (1 paper)PubMed (14 papers)
- Partner nations
- United StatesTunisiaFrance
In The Last Decade
Kaplan El
16 papers receiving 278 citations
Peers
Comparison fields: 5 of 56
- Public Health, Environmental and Occupational Health 170
- Infectious Diseases 97
- Epidemiology 130
- Clinical Biochemistry 22
- Cardiology and Cardiovascular Medicine 58
Countries citing papers authored by Kaplan El
This map shows the geographic impact of Kaplan El's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaplan El with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaplan El more than expected).
Fields of papers citing papers by Kaplan El
This network shows the impact of papers produced by Kaplan El. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaplan El. The network helps show where Kaplan El may publish in the future.
Co-authors
The 16 scholars most cited alongside Kaplan El, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. | 1984 | 136 |
| 2 | 1977 | 58 | |
| 3 | Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the young, the American Heart Association. | 1989 | 45 |
| 4 | 2004 | 23 | |
| 5 | Characterization of group A streptococci isolated in Kuala Lumpur, Malaysia. | 1995 | 11 |
| 6 | Treatment of infective endocarditis due to viridans streptococci, This statement was prepared by the ad hoc subcommittee on Treatment of Bacterial endocarditis of the American Heart Association Council on Cardiovascular Disease in the Young. | 1981 | 10 |
| 7 | Rheumatic fever in Minnesota. Current assessment of reported cases. | 1978 | 8 |
| 8 | Acute rheumatic fever in Tunisia. Serotypes of group A streptococci associated with rheumatic fever. | 1997 | 8 |
| 9 | Restriction enzyme analysis (REA) of group A streptococcal (GAS) M-serotypes 1, 3, and 28. A comparison of isolates from severe systemic infections (SSI) and from uncomplicated pharyngitis (UP): epidemiologic and pathogenetic implications. | 1997 | 4 |
| 10 | A pilot study for the primary prevention of rheumatic fever in Kosrae, Federated States of Micronesia. | 2010 | 3 |
| 11 | Cardiovascular disease in children. Reflections on the last half century and expectations for the future. | 1991 | 2 |
| 12 | Antibiotic prophylaxis for bacterial endocarditis. Necessity or tradition? | 1973 | 1 |
| 13 | Forty years of cardiac disease in children. Progress and problems--first of three parts. | 1991 | 1 |
| 14 | Epidemiology and pathogenesis of acute rheumatic fever. Recent concepts. | 1975 | 1 |
| 15 | The group A beta hemolytic streptococcus. No longer just a nuisance? | 1994 | 1 |
| 16 | Rheumatic fever in the United States: no longer a disease of the past. | 1988 | 1 |
About Kaplan El
Kaplan El is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology, Surgery, Infectious Diseases and Molecular Biology, having authored 16 papers that have together received 313 indexed citations. Recurring topics across this work include Streptococcal Infections and Treatments (11 papers), Infective Endocarditis Diagnosis and Management (7 papers), Neonatal and Maternal Infections (2 papers), Inflammasome and immune disorders (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Kawasaki Disease and Coronary Complications (2 papers), Neuroendocrine Tumor Research Advances (1 paper) and Neuroblastoma Research and Treatments (1 paper). The work is most often cited by research in Public Health, Environmental and Occupational Health (170 citations), Infectious Diseases (97 citations), Epidemiology (130 citations), Clinical Biochemistry (22 citations) and Cardiology and Cardiovascular Medicine (58 citations). Kaplan El has collaborated with scholars based in United States, Tunisia and France. Frequent co-authors include Gerber Ma, Schwartz Rh, Leon Gordis, Samuel Refetoff, A L Bisno, Richard R. Facklam, John Kim, C Watanakunakorn, Sirimon Reutrakul and Farida Jamal. Their work appears in journals such as Circulation, European Journal of Endocrinology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.